Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen ratings firms that are presently covering the stock, Marketbeat.com ...

Analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price target ...

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the Company will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 2:15 pm PT. The ...

Ascentage Pharma (6855.HK) is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in ...

Ascentage Pharma (6855.HK) is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in ...

Next up in the roster of companies trying to bring a NASH drug top market is Madrigal Pharma, with its resmetirom candidate, due to be filed for approval shortly. Viking Therapeutics (VK2809 ...

Latest on INO: Exclusive BAC Article: Inovio Pharmaceuticals; BLA Filing INO-3107 For RRP 2nd Half Of 2024, GBM Program Update INO-5401 1st Half Of 2024 And Catalysts ...

Significant stake increases in Madrigal Pharma, now the largest position at ~28% of the portfolio, and Tellurian Inc. Key holdings such as Perpetua Resources, BrightSphere Investment Group ...

This study reveals how SARS-CoV-2 infection significantly alters human milk composition, while COVID-19 vaccination causes minimal, transient changes, underscoring the safety of breastfeeding ...